CSIMarket
 


Atyr Pharma Inc  (LIFE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atyr Pharma Inc's Quick Ratio for Trailing Twelve Months Period

LIFE's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LIFE Quick Ratio for Trailing Twelve Months Period

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Growth -57.39 % -54.62 % -32.08 % -13.31 % -6.53 %
Y / Y Cash & cash equivalent Growth 1.62 % 1.75 % -5.04 % -2.27 % 15.83 %
Quick Ratio for Trailing Twelve Months Period 5.68 4.66 3.85 3.57 3.47
Total Ranking # 574 # 588 # 614 # 664 # 676
Seq. Current Liabilities Growth -24.1 % -27 % -18.02 % -6.18 % -19.18 %
Seq. Cash & cash equivalent Growth 59.79 % -12.33 % -12.76 % -16.85 % 60 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Atyr Pharma Inc Cash & cash equivalent average improved by 1.62 % in I. Quarter year on year, while Current Liabilities faded to $4 millions, this led to increase in in Atyr Pharma Inc's Quick Ratio for Trailing Twelve Months Period to 5.68, Quick Ratio for Trailing Twelve Months Period remained below Atyr Pharma Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 95 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atyr Pharma Inc. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 574, from total ranking in previous quarter at 588.

What is Quick Ratio?
Learn more about LIFE
Quick Ratio LIFE in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 96
Sector # 332
S&P 500 # 567


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.05 1.68 0.05
(March 31, 2016)   (March 31, 2012)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2021, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Arca Biopharma Inc   15.09 
Poseida Therapeutics Inc   14.89 
Satsuma Pharmaceuticals Inc   14.50 
Scpharmaceuticals Inc   14.26 
Myokardia Inc   14.14 
Vaxcyte Inc   14.13 
Eidos Therapeutics Inc   13.65 
Oxford Immunotec Global Plc  13.36 
Diffusion Pharmaceuticals Inc   13.33 
Acceleron Pharma inc  13.31 
Jounce Therapeutics inc   13.13 
Livongo Health Inc   13.01 
Curis Inc   12.81 
Immunomedics Inc   12.73 
Iovance Biotherapeutics inc   12.51 
Capricor Therapeutics Inc   12.48 
Celldex Therapeutics Inc   11.92 
Compugen Ltd  11.82 
Checkmate Pharmaceuticals Inc   11.77 
Renovacare Inc   11.64 
Syndax Pharmaceuticals Inc   11.38 
Homology Medicines Inc  10.94 
Zai Lab Limited  10.94 
Solid Biosciences Inc   10.79 
G1 Therapeutics Inc   10.77 
Fennec Pharmaceuticals Inc   10.23 
Rapt Therapeutics Inc   9.74 
Surface Oncology Inc   9.71 
Salarius Pharmaceuticals inc   9.53 
Voyager Therapeutics Inc   9.51 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SVBL's Profile

Stock Price

SVBL's Financials

Business Description

Fundamentals

Charts & Quotes

SVBL's News

Suppliers

SVBL's Competitors

Customers & Markets

Economic Indicators

SVBL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071